Abstract
BACKGROUND: The reference arm of a recent, randomized, double-blind, clinical trial (Engage) included a large cohort of patients from North American (NA) sites. Patients randomized to this reference arm were treated with a standardized rFSH/GnRH antagonist protocol but could have a day 3 or day 5 ET with one or two embryos transferred.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have